Lite Strategy: From Biotech To Litecoin Treasury (NASDAQ:LITS)

Company Overview - Lite Strategy Inc. (NASDAQ: LITS), previously known as MEI Pharma, Inc. and traded under the ticker "MEIP," was focused on oncology with two drug candidates, vorucliclib and ME-144, which were aimed at oncology combination therapies [1]. Analyst Background - The article includes a brief background of Myriam Hernandez Alvarez, who holds multiple degrees in engineering, computer science, business management, and computer applications, indicating a strong academic foundation relevant to the analysis [1]. Disclosure Information - The article contains disclosures stating that the analyst has no stock or derivative positions in the companies mentioned and has no plans to initiate any such positions within the next 72 hours [2]. - It is noted that the opinions expressed are independent and not influenced by any business relationships with the companies discussed [2].